CLINICAL ROLE -
Predictors of Relapse in Schizophrenia
Watch
Current Challenges in the Treatment of Schizophrenia
Optimal Treatment of Schizophrenia: Take-Home Messages
Overcoming Obstacles to LAIs in Schizophrenia Management
Schizophrenia: Switching to a Long-Acting Injectable
Benefit of Long Acting Injectables in Schizophrenia
Adherence to Oral Agents in Schizophrenia Management
Schizophrenia: Understanding the Impact of Adherence
Schizophrenia: Consequences of Multiple Relapses
Importance of Relapse Prevention in Schizophrenia
Unmet Needs and Challenges in Managing Schizophrenia
Partnership Designed to Improve Medication Adherence Among Patients with Type 2 Diabetes
The program launched by the Baltimore-based organizations is the first of its kind to leverage video technology and a public health practice known as Directly Observed Therapy, or DOT.
Read More
In the Age of the Drone, Are You a Dinosaur?
In 2019, you can change your destiny, or you can maintain the status quo. You have a choice: become a drone or remain a dinosaur.
Treatment for Chronic Idiopathic Constipation Receives FDA Approval
Prucalopride (Motegrity, Shire) is the only serotonin-4 receptor agonist approved for adults with Chronic Idiopathic Constipation.
FDA Approves New Drug for Chronic Idiopathic Constipation
Prucalopride (Motegrity, Shire) is the only serotonin-4 receptor agonist approved for adults with chronic idiopathic constipation.
Flu Vaccination Reminders Prove Effective for Patients With Diabetes
Influenza vaccinations among patients with diabetes rose by 20% when they were notified about scheduling their flu shot, according to a new study.
FDA OKs Chronic Idiopathic Constipation Treatment
Officials with the FDA have approved prucalopride (Motegrity, Shire) for the treatment of chronic idiopathic constipation.
The Specialty Journey: Beauty Lies in the Eyes of the Patient
Specialty pharmacy stakeholders must strike a delicate balance between cost concerns and health outcomes, while keeping the patient at the center.
Trending News Today: Poll Finds 1 in 3 Americans Delayed Medical Treatment Due to Cost
Top news of the day across the health care landscape.
Trending News Today: Study Shows Taltz Superior to Humira in Active Psoriatic Arthritis
Guselkumab Shows Superiority in Severe Plaque Psoriasis
Patients administered guselkumab achieved an improvement of 90% or more Psoriasis Area Severity Index score than those administered secukinumab.
Research Advances Towards Eye Drop for Age-Related Macular Degeneration
AMD will affect more than 200 million people globally by 2020 and has become the leading cause of blindness in developed countries.
Pharmacist Groups Urge Federal Judge to Stop CVS-Aetna Merger
Despite the completion of CVS Health’s purchase of Aetna in November, the company continues to be challenged over the merger’s potentially harmful effect on consumers and smaller competitors.
Pharmacist Groups Unite Against CVS, Aetna Merger
CVS' acquisition of Aetna continues to be challenged over the merger’s potentially harmful effect on consumers and smaller competitors.
Two pharmacist groups jointly filed a motion urging the federal judge to block CVS and Aetna from further integration while the potential negative effects are assessed.
Study: Certain NF1 Brain Tumors May Benefit from Immunotherapy
Slow-growing gliomas in patients with neurofibromatosis type 1 may be vulnerable to immunotherapy.
Trending News Today: Federal Judge Rules ACA Unconstitutional
Trending News Today: FDA OKs New Clinical Trial for Stem Cell Treatment in Multiple Sclerosis
Hepatitis C Infection in Childhood Leads to Cirrhosis at Younger Age
Study highlights the importance of testing and early intervention in young patients with hepatitis C virus.
Top Ten Drugs Linked to Overdoses
Fentanyl, heroin, hydrocodone, and methamphetamine among the most frequently mentioned drugs connected to overdoses, according to a new report from the CDC.
